JAZZ BantTM platform

ANVISA regulatory approval granted in Brazil to market the JAZZ BandTM platform

IMPLANET (Euronext: IMPL, FR0010458729, PEA-PME eligible), a medical technology company specializing in vertebral and knee-surgery implants, today announces that it…